Sanofi (SNY) extends its offer for the outstanding shares of Genzyme (GENZ) to April 1 from March 16. Meanwhile, other biotech firms focused on rare diseases say the Sanofi-Genzyme deal puts many peers into play as takeover targets.
Are you Bullish or Bearish on ?
Results for ()
Thanks for sharing your thoughts.
From other sites
at MarketWatch.com (Feb 19, 2015)
at Benzinga.com (Feb 5, 2015)
at Benzinga.com (Jan 15, 2015)
at CNBC.com (Jan 9, 2015)
at Investor's Business Daily (Jan 8, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs